Partnerships for global health

Improving global health is no longer only the job of governments, the EU, the UN or the large number of non-governmental organizations. Drug companies are also putting global health on their agendas. Engaging in partnerships is a key principle. Continue reading →

Posted in | CSR, Health, Partnerships, Social entrepreneurship
Tagged | 20 Grand Challenges, chronic diseases, CSR in drug companies, epidemic diseases in developing countries, from sick care to healthcare, global health partnerships, IFPMA, Institute for OneWorld Health, Novo Nordisk, Oxford Health Alliance, responsible pharmaceutical companies, socially innovative business concepts, Victoria Hale, World Diabetes Foundation, World Health Organization (WHO)